The recent Vimal Elaichi ad controversy has again pushed pan masala, tobacco, areca nut, and oral cancer into public discussion. Maharashtra’s Food and Drug Administration recently issued notices to Shah Rukh Khan, Ajay Devgn, and Tiger Shroff over their association with Vimal Elaichi advertisements, alleging that the advertisements could function as surrogate promotion for Vimal Pan Masala.
The issue is not simply about celebrity advertising, though. Behind the colourful packaging, catchy commercials, and familiar celebrity faces sits a much bigger public-health question about chewing products and their possible connection with serious diseases. Tobacco is a well-established oral cancer risk, while areca nut itself is also classified as carcinogenic to humans.
Why the Vimal Ad Row Matters
The Maharashtra FDA notices have brought attention to what regulators describe as surrogate advertising, where a legal product carrying a familiar brand identity may keep the brand visible even when another associated product faces restrictions. Reuters reported that the Maharashtra authority asked the actors to stop the relevant promotions and provide details about their endorsements.
That distinction matters because Vimal Elaichi and tobacco-containing pan masala should not automatically be treated as the same product. A mouth-freshener product cannot simply be declared cancer-causing because another product with a similar brand exists. In fact, the Delhi High Court dealt with a separate dispute in 2026 involving allegations that Vimal Elaichi had been falsely portrayed as containing tobacco.
Still, the broader health concern remains real. Tobacco and areca nut consumption have strong scientific links with oral cancer, and health experts have repeatedly warned that products containing these substances should not be viewed as harmless mouth fresheners.
Areca Nut Is Not Harmless
Many people still assume that the real danger in chewing products comes only from tobacco. Scientific evidence does not support that simple assumption. The International Agency for Research on Cancer has classified areca nut as carcinogenic to humans, including when it is consumed without tobacco.
Areca nut is commonly known in India as supari, and it appears in different chewing preparations across South Asia. It contains several biologically active compounds, including arecoline, which has been studied extensively because of its effects on oral tissues.
Regular chewing can also contribute to oral submucous fibrosis, a potentially serious precancerous condition that can progressively restrict mouth opening. IARC has specifically identified the connection between areca-nut chewing, oral submucous fibrosis, and oral cancer.
That is why calling every tobacco-free chewing product a safe alternative can be misleading. Removing tobacco does not automatically remove every cancer risk when areca nut remains part of the product.
Tobacco Creates Another Layer
Tobacco has an even broader and well-established relationship with cancer. It can be smoked, chewed, sucked, or used through different smokeless preparations, and these products expose users to several harmful chemicals.
IARC identifies tobacco use in different forms as a major established risk factor for oral cancer. Smokeless tobacco products can contain tobacco-specific nitrosamines and other carcinogenic substances that can damage tissues over prolonged exposure.
The danger can become particularly concerning when tobacco and areca nut are used together. Betel quid containing tobacco is known to cause cancers of the oral cavity, pharynx, and oesophagus, according to IARC evidence.
There is also an important practical problem here. Chewing products can become part of someone’s daily routine very easily. A person may start occasionally and gradually move toward repeated consumption, making the exposure longer and harder to stop.
India Faces a Heavy Burden
India has a particularly important place in this discussion because chewing tobacco and areca nut products remain widely used across the country. Recent IARC research estimated that around one-third of oral cancer cases globally in 2022 could be attributed to smokeless tobacco and areca nut use.
The figures for India are especially striking. IARC estimated that 83,400 oral cancer cases in India in 2022 were attributable to smokeless tobacco and areca nut use, according to its analysis. Among Indian men and women, different products such as khaini, gutka, betel quid with tobacco, and areca nut contributed substantial proportions of cases.
These numbers do not mean that every person consuming one of these products will develop cancer. Cancer risk depends on several factors, including the product, frequency and duration of use, individual susceptibility, and other exposures.
The numbers do show something important, however. This is not a minor or theoretical health concern for India.
What Happens Inside the Mouth
The mouth receives repeated chemical and physical exposure when someone regularly chews tobacco or areca nut. Some compounds can damage cells directly, while chronic irritation and biological changes can create an environment where abnormal tissue changes become more likely.
The effects may not appear immediately, which is one reason these habits can feel deceptively safe. Someone may chew for years without obvious symptoms and assume everything is fine.
Early warning signs should therefore never be ignored. Persistent mouth ulcers, unusual white or red patches, unexplained bleeding, difficulty opening the mouth, persistent pain, numbness, difficulty swallowing, or a lump should be medically assessed rather than dismissed as ordinary irritation.
Not every mouth ulcer means cancer, and most symptoms can have other explanations. The important point is persistence. A lesion that does not heal normally deserves professional attention, particularly in someone who uses tobacco or areca nut.
Celebrity Ads Change Perception
Celebrity advertising makes the debate more complicated because famous faces can make products appear familiar, fashionable, or socially acceptable. This effect can be especially influential among younger audiences who already recognise the actors from films and social media.
The Maharashtra FDA’s recent action reflects concern about this promotional environment. Reuters reported that the authority viewed the Vimal Elaichi promotions as potentially connected with a banned pan masala product through brand association.
There is still a legal and factual distinction between advertising a permitted elaichi product and advertising tobacco-containing pan masala. Those questions need to be decided through evidence and applicable advertising and food-safety laws.
The health discussion, meanwhile, should remain separate. Whether a particular advertisement violates a regulation is one question. Whether tobacco and areca nut can increase oral cancer risk is another question, and the scientific evidence on that second issue is already substantial.
The Bigger Problem Is Habit
Advertising controversies usually disappear from headlines after a few days. Chewing habits do not disappear that quickly. For many users, tobacco or supari becomes connected with meals, work breaks, social gatherings, stress, or simply routine.
This is where prevention becomes more useful than arguments about individual advertisements. WHO and IARC recommend avoiding or stopping tobacco and areca nut use as important measures for reducing oral cancer risk.
People who already use these products should not assume that stopping is pointless because they have consumed them for years. Quitting removes continued exposure, which is an important step toward reducing future health risks.
Professional support can also make quitting easier, particularly for people who experience strong cravings or have repeatedly tried to stop before.
What People Should Watch For
Regular self-awareness can help people notice changes inside the mouth earlier. Any persistent unusual patch, sore, swelling, bleeding area, restricted mouth movement, or unexplained pain deserves attention from a dentist or qualified medical professional.
People who consume tobacco, gutka, khaini, supari, pan masala containing areca nut, or betel quid should be especially careful about ignoring persistent symptoms. Early evaluation does not mean someone has cancer. It simply means that a potentially important problem is being checked before it has more time to progress.
Oral examinations can be relatively straightforward, and healthcare professionals can decide whether additional tests are needed. Waiting for severe pain is not a sensible screening strategy because some early oral cancers may not cause dramatic symptoms.
The Advertising Debate Is Only One Part
The Vimal Elaichi controversy has understandably attracted attention because it involves major Bollywood names and a familiar consumer brand. Yet focusing only on celebrities can make the wider health issue easier to forget.
Tobacco and areca nut remain important preventable risk factors for oral cancer, particularly in South and Southeast Asia. IARC has described smokeless tobacco and areca nut as leading causes of oral cancer in countries where these products are widely used.
So the useful question is not simply whether a particular celebrity should appear in an advertisement. A more important question concerns what consumers understand about the products being promoted, what substances they contain, and whether familiar branding can blur those differences.
That distinction matters for consumers, parents, advertisers, regulators, and celebrities alike.
A Health Message Worth Remembering
The Vimal Elaichi ad row may eventually move out of the news cycle, but the oral cancer discussion should not move with it. Tobacco use is a major established cancer risk, and areca nut is independently recognised as carcinogenic to humans.
People should therefore avoid assuming that a tobacco-free label automatically means a chewing product is completely safe, particularly when areca nut is present. At the same time, individual products should be judged on their actual ingredients rather than assumptions based only on branding.
For anyone currently using tobacco or areca nut products, quitting is one of the most meaningful steps available for lowering future oral cancer risk. Persistent mouth changes should also receive timely professional evaluation instead of being ignored.
Conclusion
The Vimal Elaichi advertisement controversy has reopened a much larger conversation about tobacco, areca nut, celebrity marketing, and oral cancer risk in India. The advertising dispute itself involves regulatory and legal questions that must be considered separately from medical evidence. What is already clear scientifically is that tobacco and areca nut are important preventable risk factors for oral cancer. Consumers should look beyond attractive packaging and familiar celebrity faces and understand what chewing products actually contain. If you use tobacco or areca nut, consider taking steps toward quitting and seek professional advice when needed.